Company intelligence / Profile preview

Casper Pharma

East Brunswick, New Jersey, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Casper Pharma commercializes a portfolio of approved small molecule drugs in the US market, with a focus on legacy and value-added branded medications primarily in cardiovascular, gastrointestinal, urological, pain, and ophthalmic therapeutic categories. Clinical activity is limited to commercial distribution; no new clinical results are reported for novel drugs[1][3][4].

Therapeutic areas: Metabolic DisordersOphthalmologyInfectious DiseasesGastroenterologyCardiovascularNeurology
Modalities: Small molecule
Industry: Non-Academic Healthcare

Partnerships

Shionogi (asset acquisition)Pfizer (asset acquisition)

Beyond the preview

Go deeper on Casper Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Casper Pharma.

Explore the full profile